Why the study?
Does MACC combination therapy improve response rate and survival in patients with advanced lung cancer?
Does MACC combination therapy improve response rate and survival in patients with advanced lung cancer?
The MACC regimen shows activity across all cell types of advanced lung cancer and significantly prolongs survival in patients who respond to therapy.
No takes yet. Share an insight, caveat, or question.
MACC responses linked to longer survival; hypothesis-generating for advanced lung cancer and requires randomized confirmation.
Chahinian et al. (1979) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: